New research showed that tirzepatide, the compound in Zepbound, improved symptoms of obstructive sleep apnea.

In recent research led by the University of California San Diego School of Medicine, scientists have found a new potential treatment for obstructive...

Researchers at University of California San Diego School of Medicine and international collaborators have led a worldwide, advanced study...

Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most common sleep-related breathing...

Eli Lilly (LLY) files for the approval of tirzepatide to treat obstructive sleep apnea in adults with obesity in the United States. If approved, sales...

People with type 2 diabetes who are treated with GLP-1 agonists have a decreased risk of developing dementia, according to a new study from...

TUESDAY, July 2, 2024 -- Cutting-edge weight-loss drugs like Wegovy and Ozempic can help treat alcoholism, a new study says. People taking semaglutide...

Locate a scholarly article that outlines a complimentary/self-help/alternative treatment for anxiety. Describe the evidence regarding the...

WEDNESDAY, June 26, 2024 -- Tirzepatide reduces the apnea-hypopnea index (AHI) among individuals with moderate-to-severe obstructive sleep apnea and...

Novo Nordisk’s popular weight loss drug Wegovy has been approved for the treatment of severe obesity in China. “We can confirm that Wegovy has...